RT-156
|
Use of flecainide before, during
and after electrical cardioversion of chronic atrial fibrillation
|
|
|
Marcello Chimienti, Giampaolo
Guazzotti*, Serena Barbieri*.
Section of Cardiology, Department of Internal Medicine, University of Pavia,
*Policlinic of Monza, Monza, Italy
|
|
Study population
|
|
Eighty-five consecutive patients with CAF underwent a
total of 120 ECV; their mean age was 62 ± 10 years, the mean left atrium diameter was
49.4 ± 8.1 mm; 82% of them had an associated heart disease. A history of arrhythmias had
been present for a mean of 25 months (range: 0.5-324 months) while the mean duration of
the last episode leading to ECV was 76 days, with a range from 2 days to more than 3
years. Table I reports the main clinical characteristics of the patients.
TABLE I - Study population
Patients
|
85 (43 M/42 F)
|
Electrical cardioversions
|
120
|
Age
|
62 ± 10 years
|
Left atrium size
|
49.4 ± 8.1 mm
|
Associated heart disease
|
70/85 (82%)
|
History of arrhythmia (months)
|
25 ± 51 (range: 0.5-324)
|
Duration of AF episode (days)
|
76 ± 169 (range: 2-1140)
|
|
